These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7907345)

  • 1. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
    Pfaller MA; Rhine-Chalberg J; Redding SW; Smith J; Farinacci G; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1994 Jan; 32(1):59-64. PubMed ID: 7907345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
    Barchiesi F; Hollis RJ; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
    Clin Infect Dis; 1995 Mar; 20(3):634-40. PubMed ID: 7756488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
    Redding SW; Pfaller MA; Messer SA; Smith JA; Prows J; Bradley LL; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1997 Jul; 35(7):1761-5. PubMed ID: 9196188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
    Barchiesi F; Hollis RJ; Del Poeta M; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
    Clin Infect Dis; 1995 Sep; 21(3):561-4. PubMed ID: 8527544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
    Redding S; Smith J; Farinacci G; Rinaldi M; Fothergill A; Rhine-Chalberg J; Pfaller M
    Clin Infect Dis; 1994 Feb; 18(2):240-2. PubMed ID: 8161633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
    Le Guennec R; Reynes J; Mallié M; Pujol C; Janbon F; Bastide JM
    J Clin Microbiol; 1995 Oct; 33(10):2732-7. PubMed ID: 8567915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Lopez-Ribot JL; McAtee RK; Kirkpatrick WR; La Valle R; Patterson TF
    Clin Diagn Lab Immunol; 1999 Sep; 6(5):665-70. PubMed ID: 10473514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
    Diaz-Guerra TM; Martinez-Suarez JV; Laguna F; Valencia E; Rodriguez-Tudela JL
    AIDS; 1998 Sep; 12(13):1601-10. PubMed ID: 9764778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patient.
    Takasuka T; Baily GG; Birch M; Anderson MJ; Law D; Denning DW
    J Infect; 1998 Jan; 36(1):57-62. PubMed ID: 9515670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.
    Sangeorzan JA; Bradley SF; He X; Zarins LT; Ridenour GL; Tiballi RN; Kauffman CA
    Am J Med; 1994 Oct; 97(4):339-46. PubMed ID: 7942935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates.
    Dromer F; Improvisi L; Dupont B; Eliaszewicz M; Pialoux G; Fournier S; Feuillie V
    AIDS; 1997 Jul; 11(9):1095-101. PubMed ID: 9233455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
    Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.
    Barchiesi F; Najvar LK; Luther MF; Scalise G; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1996 May; 40(5):1317-20. PubMed ID: 8723495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
    Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
    J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Walsh TJ; Gonzalez CE; Piscitelli S; Bacher JD; Peter J; Torres R; Shetti D; Katsov V; Kligys K; Lyman CA
    J Clin Microbiol; 2000 Jun; 38(6):2369-73. PubMed ID: 10835005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
    J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.